VAMYCIN 1000 mg/1 bočica prašak za rastvor za injekciju Bosnia-Hercegovina - kroatisk - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

vamycin 1000 mg/1 bočica prašak za rastvor za injekciju

licentis doo sarajevo - vankomicin - prašak za rastvor za injekciju - 1000 mg/1 bočica - 1 bočica sa praškom za rastvor za injekciju sadrži: 1000 mg vankomicina (u obliku 1025 mg vankomicin hidrohlorida)

VAMYCIN 500 mg/1 bočica prašak za rastvor za injekciju Bosnia-Hercegovina - kroatisk - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

vamycin 500 mg/1 bočica prašak za rastvor za injekciju

licentis doo sarajevo - vankomicin - prašak za rastvor za injekciju - 500 mg/1 bočica - 1 bočica sa praškom za rastvor za injekciju sadrži: 500 mg vankomicina (u obliku 512,5 mg vankomicin hidrohlorida)

Rozor 10 mg/10 mg filmom obložene tablete Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

rozor 10 mg/10 mg filmom obložene tablete

mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - rosuvastatinkalcij ezetimib - filmom obložena tableta - 10 mg + 10 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg rosuvastatina (u obliku kalcija) i 10 mg ezetimiba

Rozor 20 mg/10 mg filmom obložene tablete Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

rozor 20 mg/10 mg filmom obložene tablete

mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - rosuvastatinkalcij ezetimib - filmom obložena tableta - 20 mg + 10 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg rosuvastatina (u obliku kalcija) i 10 mg ezetimiba

Lonsurf Den europeiske union - kroatisk - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Lunsumio Den europeiske union - kroatisk - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Carvykti Den europeiske union - kroatisk - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multipli mijelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Tecvayli Den europeiske union - kroatisk - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multipli mijelom - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Talvey Den europeiske union - kroatisk - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - multipli mijelom - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Gefitinib Pliva 250 mg filmom obložene tablete Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

gefitinib pliva 250 mg filmom obložene tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna filmom obložena tableta sadrži 250 mg gefitiniba